Breast Carcinoma In Situ: all 145 studies
Page 1 of 2. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer SurvivorsRecruitingNCT07699991Not applicable
- A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS TrialRecruitingNCT07443943Phase 2
- CAN1012 in Pre-Malignant DCIS and LCISRecruitingNCT07408856Phase 1
- 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone LossRecruitingNCT07044310Phase 2
- A Study of Revaree Plus in People With Breast CancerRecruitingNCT07042581Phase 4
- Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast CancerRecruitingNCT06984250
- Ways of Retaining the Inframammary Fold in Implant-based Breast SurgeryRecruitingNCT06931548Not applicable
- Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II StudyEnrolling by invitationNCT06843681Phase 2
- Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor TherapyRecruitingNCT06401889
- Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)RecruitingNCT06401304
- Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving SurgeryRecruitingNCT06297265Not applicable
- Optimizing Surgical Decisions in Young Adults With Breast CancerRecruitingNCT06275126Not applicable
- The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCISNot yet recruitingNCT06217458Not applicable
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk ReductionRecruitingNCT06195306Phase 2
- Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE TrialRecruitingNCT06184750Phase 2
- Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and ReconstructionRecruitingNCT06153836Phase 2
- EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast CancerRecruitingNCT06115486Not applicable
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast CancerRecruitingNCT05941520Phase 2
- Virtual Rehabilitation for Cancer SurvivorsRecruitingNCT05898789Not applicable
- Impact of Dietary Inflammatory Potential on Breast Cancer RiskRecruitingNCT05178498
- Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast CancerRecruitingNCT04959474Not applicable
- Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast CancerRecruitingNCT04603209
- CONFIRM: Magnetic Resonance Guided Radiation TherapyRecruitingNCT04368702Not applicable
- Prospective Breast Cancer Biospecimen CollectionRecruitingNCT04074720
- The PREDICT Registry:RecruitingNCT03448926
- Women Informed to Screen Depending on Measures of Risk (Wisdom Study)RecruitingNCT02620852Not applicable
- Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast CancerRecruitingNCT02389673Not applicable
- Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID StudyCompletedNCT05545150Phase 2Results posted
- EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast CancerCompletedNCT05086705Not applicableResults posted
- Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving PaclitaxelCompletedNCT04862585Phase 2/3Results posted
- Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer RiskTerminatedNCT04570956Phase 2Results posted
- Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerCompletedNCT04081389Phase 1Results posted
- Increasing Patients' Engagement in Breast Cancer Surgery Decision-MakingCompletedNCT03766009Not applicableResults posted
- Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast CancerCompletedNCT03345420Phase 2Results posted
- Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast CancerCompletedNCT03323658Phase 1Results posted
- Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast SurgeryActive, not recruitingNCT03317405Phase 1Results posted
- Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast CancerCompletedNCT03139435Not applicableResults posted
- Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic MastectomyCompletedNCT03061175Not applicableResults posted
- Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the BreastCompletedNCT02993159Phase 2Results posted
- Oxybutynin Chloride in Managing Hot FlashesCompletedNCT02961790Phase 3Results posted
- Ruxolitinib for Premalignant Breast DiseaseCompletedNCT02928978Phase 2Results posted
- S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)CompletedNCT02728596Not applicableResults posted
- eHealth Weight Loss Program in African American Breast Cancer SurvivorsCompletedNCT02699983Not applicableResults posted
- Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast CancerCompletedNCT02598557Phase 2Results posted
- Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast CancerCompletedNCT02556632Phase 2Results posted
- Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After SurgeryCompletedNCT02526498Phase 2Results posted
- Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing MastectomyCompletedNCT02314156Phase 2Results posted
- Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast CancerTerminatedNCT02137252Phase 2Results posted
- Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast CancerActive, not recruitingNCT01905046Phase 3Results posted
- Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast CancerCompletedNCT01869764Phase 2Results posted
- Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer SurvivorsCompletedNCT01849250Phase 2Results posted
- Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended BreastCompletedNCT01841749Results posted
- Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation TherapyCompletedNCT01819233Not applicableResults posted
- Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing SurgeryTerminatedNCT01754519Phase 2Results posted
- Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast CancerCompletedNCT01556243Phase 2Results posted
- Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast CancerCompletedNCT01293032Not applicableResults posted
- 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in SituCompletedNCT00952731Phase 2Results posted
- Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In SituCompletedNCT00555152Not applicableResults posted
- Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the BreastCompletedNCT00496808Not applicableResults posted
- Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialSuspendedNCT06671912Phase 3
- High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast CancerSuspendedNCT06538389Phase 2
- Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 )CompletedNCT06335108
- Multi-Institutional Transgender & Gender-Diverse Breast Cancer StudyCompletedNCT06234488
- Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)CompletedNCT06106282
- Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTionCompletedNCT06033092Phase 2
- Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst CaActive, not recruitingNCT06008158Phase 2
- FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk AssessmentsCompletedNCT05810025Not applicable
- Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic WomenTerminatedNCT05755269
- Patient Reported Outcomes After Oncoplastic Breast Conserving SurgeryStatus unknownNCT05724758
- LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer PatientsActive, not recruitingNCT05410951
- Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.Active, not recruitingNCT05318274Not applicable
- An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)CompletedNCT05263362
- An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer SurvivorsCompletedNCT05012176Not applicable
- Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast CancerCompletedNCT04999917Not applicable
- Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer SurvivorsCompletedNCT04999826
- Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE StudyActive, not recruitingNCT04993313Not applicable
- Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer SurvivorsActive, not recruitingNCT04906200Not applicable
- Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast CancerActive, not recruitingNCT04871516Not applicable
- Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast CarcinomaActive, not recruitingNCT04849871Not applicable
- Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal StudyActive, not recruitingNCT04754412Not applicable
- Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast CancerCompletedNCT04693338Phase 1
- Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider InterventionsActive, not recruitingNCT04549571Not applicable
- Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast CancerCompletedNCT04535323Phase 1
- Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)Active, not recruitingNCT04496739Not applicable
- Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer SurvivorsCompletedNCT04290897Phase 2
- Factors Affecting Functionality in Breast Cancer SurvivorsCompletedNCT04245657
- Genetic Testing for All Breast Cancer Patients (GET FACTS)CompletedNCT04245176Not applicable
- Immediate Breast Reconstruction With Acellular Dermal MatrixCompletedNCT04209010
- Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer SurvivorsCompletedNCT04200482Phase 2
- Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deletedTerminatedNCT04185311Phase 1
- Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy AdherenceCompletedNCT04054557Not applicable
- Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast CancerTerminatedNCT03979508Phase 2
- Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast LesionsWithdrawnNCT03868475Not applicable
- Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal AtrophyWithdrawnNCT03666819Phase 2
- MRI Characterization of Mammographically Detected DCISActive, not recruitingNCT03495011
- SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast CancerCompletedNCT03411070Early Phase 1
- Kindness Interventions in Enhancing Well-Being in Breast Cancer SurvivorsCompletedNCT03319342Not applicable
- Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnNCT03238703Phase 4
- Axillary Reverse Mapping (ARM) TechniqueStatus unknownNCT03109522Not applicable
- Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast CancerSuspendedNCT03077841Phase 2/3